scispace - formally typeset
G

G Cossu

Researcher at University of Cagliari

Publications -  26
Citations -  3871

G Cossu is an academic researcher from University of Cagliari. The author has contributed to research in topics: Cannabinoid & Cannabinoid receptor. The author has an hindex of 21, co-authored 26 publications receiving 3740 citations. Previous affiliations of G Cossu include Université libre de Bruxelles.

Papers
More filters
Journal ArticleDOI

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice

TL;DR: Observations suggest that the CB1 receptor is involved in the motivational properties of opiates and in the development of physical dependence and extend the concept of an interconnected role of CB1 and opiate receptors in the brain areas mediating addictive behavior.
Journal ArticleDOI

Crucial Role of α4 and α6 Nicotinic Acetylcholine Receptor Subunits from Ventral Tegmental Area in Systemic Nicotine Self-Administration

TL;DR: The necessary and sufficient role of α4β2- and α6 β2-subunit containing nicotinic receptors, but not α7*-nAChRs, present in cell bodies of the VTA, and their axons, for systemic nicotine reinforcement in drug-naive mice are defined.
Journal ArticleDOI

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse.

TL;DR: The results of the present study indicate that morphine did not induce intravenous self-administration in mutant CB1 receptor knockout mice, whereas it was significantly self- Administered by the corresponding wild type mice.
Journal ArticleDOI

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice.

TL;DR: It is shown how WIN 55,212-2 is able to elicit both rewarding and aversive effects depending on the concentration used, and Pretreatment of mice with the cannabinoid CB1 receptor antagonist SR 141716A completely prevented WIN55, 212-2 self-administration, indicating that WIN 55adays rewarding effects are specifically mediated by cannabinoids CB1 receptors.